share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Shanahan Karin

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Shanahan Karin

施貴寶 | 4：持股變動聲明-高管 Shanahan Karin
美股sec公告 ·  04/02 18:50
Moomoo AI 已提取核心訊息
On April 1, 2024, Karin Shanahan, EVP of Global Product Development & Supply at Bristol-Myers Squibb (BMY), completed a stock transaction involving the company's common stock. Shanahan exercised options to acquire 3,306 shares at no cost and subsequently sold 1,196 shares at a price of $52.99 per share, resulting in a total sale value of $63,376.04. Following these transactions, Shanahan directly holds 5,336 shares of Bristol-Myers Squibb. Additionally, Shanahan has an indirect ownership of 818.59 shares through the BMS Savings and Investment Program.
On April 1, 2024, Karin Shanahan, EVP of Global Product Development & Supply at Bristol-Myers Squibb (BMY), completed a stock transaction involving the company's common stock. Shanahan exercised options to acquire 3,306 shares at no cost and subsequently sold 1,196 shares at a price of $52.99 per share, resulting in a total sale value of $63,376.04. Following these transactions, Shanahan directly holds 5,336 shares of Bristol-Myers Squibb. Additionally, Shanahan has an indirect ownership of 818.59 shares through the BMS Savings and Investment Program.
2024年4月1日，百時美施貴寶（BMY）全球產品開發與供應執行副總裁卡琳·沙納漢完成了一項涉及該公司普通股的股票交易。沙納漢行使期權免費收購了3,306股股票，隨後以每股52.99美元的價格出售了1,196股股票，總銷售價值爲63,376.04美元。在這些交易之後，沙納漢直接持有百時美施貴寶的5,336股股份。此外，沙納漢通過BMS儲蓄和投資計劃間接擁有818.59股股票的所有權。
2024年4月1日，百時美施貴寶（BMY）全球產品開發與供應執行副總裁卡琳·沙納漢完成了一項涉及該公司普通股的股票交易。沙納漢行使期權免費收購了3,306股股票，隨後以每股52.99美元的價格出售了1,196股股票，總銷售價值爲63,376.04美元。在這些交易之後，沙納漢直接持有百時美施貴寶的5,336股股份。此外，沙納漢通過BMS儲蓄和投資計劃間接擁有818.59股股票的所有權。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息